Quantcast

Testing of a Tool for Prostate Cancer Screening Discussions in Primary Care.

Research paper by Anita D AD Misra-Hebert, Grant G Hom, Eric A EA Klein, Janine M JM Bauman, Niyati N Gupta, Xinge X Ji, Andrew J AJ Stephenson, J Stephen JS Jones, Michael W MW Kattan

Indexed on: 14 Jul '18Published on: 14 Jul '18Published in: Frontiers in oncology



Abstract

As prostate cancer (PCa) screening decisions often occur in outpatient primary care, a brief tool to help the PCa screening conversation in busy clinic settings is needed. A previously created 9-item tool to aid PCa screening discussions was tested in five diverse primary care clinics. Fifteen providers were recruited to use the tool for 4 weeks, and the tool was revised based upon feedback. The providers then used the tool with a convenience sample of patients during routine clinic visits. Pre- and post-visit surveys were administered to assess patients' knowledge of the option to be screened for PCa and of specific factors to consider in the decision. McNemar's and Stuart-Maxwell tests were used to compare pre-and post-survey responses. 14 of 15 providers completed feedback surveys and had positive responses to the tool. All 15 providers then tested the tool on 95 men aged 40-69 at the five clinics with 2-10 patients each. The proportion of patients who strongly agreed that they had the option to choose to screen for PCa increased from 57 to 72% ( = 0.018) from the pre- to post-survey, that there are factors in the personal or family history that may affect PCa risk from 34 to 47% ( = 0.012), and that their opinions about possible side effects of treatment for PCa should be considered in the decision from 47 to 61% ( = 0.009). A brief conversation tool for the PCa screening discussion was well received in busy primary-care settings and improved patients' knowledge about the screening decision.

More like this: